AstraZeneca Backs $1 Billion Fund for China Biotech Startups

(Bloomberg) -- AstraZeneca Plc is teaming up with one of China’s largest investment banks on a $1 billion biotechnology venture capital fund as the U.K. drugmaker builds presence in the fast-growin...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.